CERS Cerus Corporation Stock Quote

CERS [NASD]

Index	-	P/E	-	EPS (ttm)	-0.40	Insider Own	0.90%	Shs Outstand	166.57M	Perf Week	-12.65%
Market Cap	1.10B	Forward P/E	-	EPS next Y	-0.31	Insider Trans	-30.11%	Shs Float	163.66M	Perf Month	-6.75%
Income	-62.40M	PEG	-	EPS next Q	-0.09	Inst Own	83.80%	Short Float	5.56%	Perf Quarter	8.67%
Sales	107.10M	P/S	10.30	EPS this Y	-16.50%	Inst Trans	1.92%	Short Ratio	4.37	Perf Half Y	-4.24%
Book/sh	0.66	P/B	10.26	EPS next Y	16.20%	ROA	-30.80%	Target Price	9.30	Perf Year	34.59%
Cash/sh	0.83	P/C	8.16	EPS next 5Y	-	ROE	-63.50%	52W Range	2.71 - 8.87	Perf YTD	-2.17%
Dividend	-	P/FCF	-	EPS past 5Y	0.30%	ROI	-65.50%	52W High	-24.41%	Beta	1.35
Dividend %	-	Quick Ratio	3.40	Sales past 5Y	20.80%	Gross Margin	64.30%	52W Low	147.42%	ATR	0.48
Employees	254	Current Ratio	3.80	Sales Q/Q	28.10%	Oper. Margin	-56.40%	RSI (14)	38.78	Volatility	6.91% 6.58%
Optionable	Yes	Debt/Eq	0.41	EPS Q/Q	33.40%	Profit Margin	-58.20%	Rel Volume	0.62	Prev Close	6.77
Shortable	Yes	LT Debt/Eq	0.36	Earnings	Feb 25 AMC	Payout	-	Avg Volume	2.08M	Price	6.70
Recom	1.40	SMA20	-7.96%	SMA50	-8.50%	SMA200	1.42%	Volume	1,101,593	Change	-0.96%

Oct-08-20

Resumed

BTIG Research

Buy

Jun-16-20

Resumed

Cantor Fitzgerald

Overweight

Feb-26-20

Initiated

BTIG Research

Buy

Nov-13-19

Upgrade

BTIG Research

Neutral → Buy

Aug-28-19

Initiated

Stifel

Buy

Aug-23-19

Resumed

Stephens

Overweight

Jan-05-18

Resumed

Cantor Fitzgerald

Overweight

Dec-08-17

Resumed

BTIG Research

Neutral

Jul-07-16

Resumed

Cantor Fitzgerald

Buy

Dec-17-15

Downgrade

Wedbush

Outperform → Neutral

May-02-14

Reiterated

MLV & Co

Buy

$8.50 → $6

Apr-24-13

Reiterated

Cantor Fitzgerald

Buy

$5.50 → $6

Mar-15-13

Reiterated

MLV & Co

Buy

$7.50 → $8.50

Apr-17-12

Initiated

Cantor Fitzgerald

Buy

$5.50

Feb-29-12

Upgrade

Robert W. Baird

Neutral → Outperform

$3 → $6

Nov-10-11

Reiterated

MLV & Co

Buy

$4 → $5

Jun-03-11

Initiated

Wedbush

Outperform

Mar-04-11

Downgrade

Robert W. Baird

Outperform → Neutral

$4 → $3

Mar-09-10

Upgrade

Robert W. Baird

Neutral → Outperform

$3 → $5

Aug-26-09

Upgrade

Avondale

Mkt Perform → Mkt Outperform

$2 → $5

Feb-24-21 10:14AM	A Preview Of Cerus's Earnings Benzinga
Feb-11-21 08:30AM	Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 Business Wire
Feb-05-21 01:39AM	Do Institutions Own Cerus Corporation (NASDAQ:CERS) Shares? Simply Wall St.
Feb-04-21 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire
Jan-23-21 11:30PM	Money Supply Is Up 26%, Inflation Coming? Cathie Woods Bitcoin Comments and Stock Picks Insider Monkey
Jan-11-21 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2020 Product Revenue Business Wire
Dec-15-20 08:30AM	Cerus Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets Business Wire
Dec-11-20 10:55PM	Is CERS A Good Stock To Buy Now? Insider Monkey
Dec-07-20 12:11AM	Cerus (NASDAQ:CERS) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Dec-04-20 07:00PM	Cerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual Meeting Business Wire
Nov-30-20 12:00PM	Cerus (CERS) Is Up 2.47% in One Week: What You Should Know Zacks
08:30AM	Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation Business Wire
Nov-20-20 12:00PM	All You Need to Know About Cerus (CERS) Rating Upgrade to Buy Zacks
Nov-12-20 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire
Nov-01-20 07:59AM	Cerus Corporation (NASDAQ:CERS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
Oct-30-20 03:30PM	Cerus Corporation (CERS) Q3 2020 Earnings Call Transcript Motley Fool -5.49%
Oct-29-20 06:05PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:02PM	Cerus Corporation Announces Record Third Quarter 2020 Results Business Wire
02:30PM	Cerus Corp.to Host Earnings Call ACCESSWIRE
Oct-28-20 10:13AM	Earnings Outlook for Cerus Benzinga -6.88%
Oct-22-20 12:34PM	Cerus (CERS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
07:44AM	Is Cerus' (NASDAQ:CERS) 120% Share Price Increase Well Justified? Simply Wall St.
Oct-19-20 08:30AM	Cerus Corporation to Release Third Quarter 2020 Financial Results on October 29, 2020 Business Wire
Oct-13-20 08:30AM	Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole Blood Business Wire
Sep-28-20 08:30AM	Cerus Corporation Announces Schedule of Presentations at the AABB 2020 Virtual Annual Meeting Business Wire
Sep-16-20 07:49AM	Key Things To Understand About Cerus' (NASDAQ:CERS) CEO Pay Cheque Simply Wall St.
Sep-09-20 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire +5.28%
Aug-26-20 01:08PM	The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS Zacks
Aug-25-20 08:38AM	The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout Benzinga -7.54%
Aug-12-20 09:26AM	Did Hedge Funds Make The Right Call On Cerus Corporation (CERS) ? Insider Monkey
Aug-11-20 06:48AM	Have Insiders Been Buying Cerus Corporation (NASDAQ:CERS) Shares This Year? Simply Wall St.
Aug-07-20 08:30AM	Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch Business Wire
Aug-05-20 02:01AM	Cerus Corporation (CERS) Q2 2020 Earnings Call Transcript Motley Fool
Aug-04-20 05:15PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:02PM	Cerus Corporation Announces Record Second Quarter 2020 Results Business Wire
Jul-30-20 08:30AM	Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems Business Wire
Jul-28-20 12:33PM	Cerus (CERS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-23-20 08:30AM	Cerus Corporation to Release Second Quarter 2020 Financial Results on August 4, 2020 Business Wire
Jul-07-20 08:30AM	Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma Business Wire
Jul-06-20 10:01AM	What Kind Of Shareholders Hold The Majority In Cerus Corporation's (NASDAQ:CERS) Shares? Simply Wall St.
Jun-24-20 03:17PM	Cerus Corporation (CERS): Hedge Funds Getting Bullish Insider Monkey
Jun-17-20 11:30AM	Is Cerus (CERS) Outperforming Other Medical Stocks This Year? Zacks
Jun-15-20 05:43PM	Edited Transcript of CERS.OQ earnings conference call or presentation 5-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-12-20 08:30AM	Cerus Corporation Celebrates World Blood Donor Day Business Wire +7.86%
Jun-11-20 09:39AM	Cerus Shows Potential for Further Gains but Limit Your Risk TheStreet.com -15.92%
May-27-20 12:00PM	Cerus (CERS) Upgraded to Buy: What Does It Mean for the Stock? Zacks
May-26-20 08:30AM	Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex Business Wire
May-07-20 12:15PM	Cerus Corporation (NASDAQ:CERS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
May-06-20 07:33AM	Cerus Corporation (CERS) Q1 2020 Earnings Call Transcript Motley Fool
May-05-20 06:45PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	Cerus Corporation Announces First Quarter 2020 Results Business Wire
May-04-20 08:30AM	Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits Business Wire -7.47%
Apr-29-20 10:05AM	Moving Average Crossover Alert: Cerus Zacks
Apr-28-20 12:34PM	Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know Zacks
Apr-24-20 08:30AM	Cerus Corporation to Release First Quarter 2020 Financial Results on May 5, 2020 Business Wire +5.50%
Apr-23-20 11:43AM	Cerus Corporation (CERS) Shares March Higher, Can It Continue? Zacks
Apr-20-20 05:50PM	Cerus Corporation Announces Expansion of BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells Business Wire
Apr-07-20 08:40AM	Introducing Cerus (NASDAQ:CERS), The Stock That Dropped 26% In The Last Year Simply Wall St.
Apr-06-20 08:30AM	Cerus Corporation Provides Update on COVID-19 Related Activities Business Wire +6.35%
Apr-02-20 08:30AM	University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent Plasma Business Wire
08:30AM	Cerus Corporation Announces the Inclusion of Pathogen Reduction Technology in the ISBT Working Party Recommendations for the Preparation of COVID-19 Convalescent Plasma Business Wire
Mar-26-20 08:30AM	Cerus Forms Group to Research Optimal Production of COVID-19 Convalescent Plasma Business Wire +7.92%
Mar-02-20 04:56PM	Edited Transcript of CERS earnings conference call or presentation 20-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
04:10PM	Cerus Corporation Announces Strategic Organizational Changes Business Wire
Feb-25-20 03:25PM	18 Medical Stocks To Watch Amid The Coronavirus Outbreak Benzinga
08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences Business Wire
Feb-22-20 07:58AM	Cerus Corporation Just Reported, And Analysts Assigned A US$8.25 Price Target Simply Wall St.
Feb-20-20 04:01PM	Cerus Corporation Announces Record Fourth Quarter and Full Year 2019 Financial Results Business Wire
Feb-18-20 08:30AM	U.S. Department of Defense Awards Funding for Study to Evaluate the Use of INTERCEPT Plasma in Traumatic Burn Resuscitation Business Wire
Feb-12-20 08:30AM	Cerus Corporation to Release Fourth Quarter and Full Year 2019 Financial Results on February 20, 2020 Business Wire
Feb-06-20 06:06AM	Trade Alert: The Independent Director Of Cerus Corporation (NASDAQ:CERS), Franklin Witney, Has Just Spent US$100k Buying Shares Simply Wall St.
Jan-31-20 04:01PM	Cerus Corporation Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Jan-29-20 09:00AM	Cerus Corporation Announces Pricing of Upsized Public Offering of Common Stock Business Wire
Jan-28-20 04:01PM	Cerus Corporation Announces Public Offering of Common Stock Business Wire -7.57%
Jan-23-20 03:14PM	The latest coronavirus stock screamers: Inovio Pharmaceuticals, Co-Diagnostics MarketWatch
01:02PM	13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak Benzinga
08:30AM	Coronavirus Inactivation Reported in Recent INTERCEPT Blood System Publication in Transfusion Medicine Business Wire
Jan-21-20 08:30AM	French Hemovigilance Report Highlights Safety and Effectiveness of INTERCEPT Platelets During First Full Year of 100% Production and Routine Use Business Wire +10.07%
Jan-13-20 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2019 Product Revenue Business Wire -7.91%
Dec-30-19 02:08PM	Is Cerus (NASDAQ:CERS) Using Debt Sensibly? Simply Wall St.
Dec-16-19 04:38PM	Cerus Corporation (CERS): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-12-19 08:30AM	Cerus Corporation Announces New Five-Year INTERCEPT Blood System Agreement With Swiss Transfusion SRC Business Wire
Nov-30-19 09:01AM	Edited Transcript of CERS earnings conference call or presentation 30-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
Nov-13-19 08:30AM	Cerus Corporation to Present at the Stifel 2019 Healthcare Conference Business Wire
Nov-12-19 06:45AM	How Should Investors React To Cerus Corporation's (NASDAQ:CERS) CEO Pay? Simply Wall St.
Nov-08-19 08:30AM	Cerus Corporation to Present at the Stephens Nashville Investment Conference Business Wire
Nov-01-19 09:34AM	Were Hedge Funds Right About Cashing Out Of Cerus Corporation (CERS)? Insider Monkey +6.67%
07:38AM	The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga
Oct-30-19 06:45PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	Cerus Corporation Announces Third Quarter 2019 Results Business Wire
Oct-23-19 10:34AM	Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-21-19 08:30AM	Cerus Corporation to Release Third Quarter 2019 Results and to Discuss Recent FDA Guidance for Bacterial Safety of Platelets on October 30, 2019 Business Wire
Oct-18-19 08:30AM	Cerus Corporation Announces Schedule of Presentations at the 2019 AABB Annual Meeting Business Wire
Oct-13-19 09:36AM	How Much Are Cerus Corporation (NASDAQ:CERS) Insiders Taking Off The Table? Simply Wall St.
Sep-30-19 12:00PM	Cerus Corporation Applauds the Publication of the Final Guidance Document on Bacterial Safety Standards for Platelet Collection and Transfusion Business Wire +6.07%
Sep-27-19 08:30AM	Cerus Corporation to Present at the 2019 Cantor Global Healthcare Conference Business Wire
Sep-13-19 07:05AM	Did You Miss Cerus's (NASDAQ:CERS) 32% Share Price Gain? Simply Wall St.
Sep-03-19 06:02PM	Edited Transcript of CERS earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-28-19 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences Business Wire
Aug-14-19 09:44AM	What Kind Of Shareholder Appears On The Cerus Corporation's (NASDAQ:CERS) Shareholder Register? Simply Wall St.

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma that is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company has a collaboration with the National Trauma Institute to supply Intercept plasma for use in the plasma resuscitation without lung injury (PROpOLIs) clinical study. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Swisher Daniel N JR	Director	Feb 16	Option Exercise	2.90	10,000	29,000	69,868	Feb 18 06:46 PM
Swisher Daniel N JR	Director	Feb 16	Sale	7.78	10,000	77,797	59,868	Feb 18 06:46 PM
Menard Chrystal	Chief Legal Officer	Feb 08	Option Exercise	4.33	8,125	35,142	52,752	Feb 11 05:59 PM
Menard Chrystal	Chief Legal Officer	Feb 08	Sale	8.00	8,125	65,000	48,585	Feb 11 05:59 PM
Jayaraman Vivek K	Chief Operating Officer	Dec 22	Option Exercise	4.32	56,105	242,400	188,440	Dec 28 05:44 PM
ANDERSON TIMOTHY B	Director	Dec 22	Option Exercise	5.40	30,000	162,000	240,101	Dec 28 05:39 PM
Menard Chrystal	Chief Legal Officer	Dec 22	Option Exercise	4.37	211,327	923,379	134,001	Dec 28 05:43 PM
ANDERSON TIMOTHY B	Director	Dec 22	Sale	8.31	39,336	326,856	200,765	Dec 28 05:39 PM
Menard Chrystal	Chief Legal Officer	Dec 22	Sale	8.00	211,327	1,690,616	48,585	Dec 28 05:43 PM
Jayaraman Vivek K	Chief Operating Officer	Dec 22	Sale	8.00	56,105	448,840	135,003	Dec 28 05:44 PM
SCHULZE GAIL	Director	Dec 14	Option Exercise	2.48	15,000	37,200	62,393	Dec 15 08:51 PM
SCHULZE GAIL	Director	Dec 14	Sale	7.32	62,393	456,817	0	Dec 15 08:51 PM
Jayaraman Vivek K	Chief Commercial Officer	Dec 11	Option Exercise	4.33	18,895	81,815	178,898	Dec 15 08:44 PM
Menard Chrystal	Chief Legal Officer	Dec 11	Option Exercise	4.43	41,363	183,383	70,460	Dec 15 08:49 PM
Menard Chrystal	Chief Legal Officer	Dec 11	Sale	8.00	41,363	330,904	48,585	Dec 15 08:49 PM
Jayaraman Vivek K	Chief Commercial Officer	Dec 11	Sale	8.00	43,895	351,160	135,003	Dec 15 08:44 PM
Swisher Daniel N JR	Director	Nov 17	Option Exercise	2.90	10,000	29,000	69,868	Nov 19 05:07 PM
Swisher Daniel N JR	Director	Nov 17	Sale	6.25	10,000	62,505	59,868	Nov 19 05:07 PM
Green Kevin Dennis	Chief Financial Officer	Nov 10	Sale	5.49	32,928	180,862	99,468	Nov 12 06:57 PM
Greenman William Mariner	President and CEO	Aug 26	Option Exercise	3.00	100,000	300,000	925,849	Aug 26 08:23 PM
ANDERSON TIMOTHY B	Director	Aug 24	Option Exercise	4.80	23,703	113,774	226,109	Aug 26 08:18 PM
Benjamin Richard J	Chief Medical Officer	Aug 24	Option Exercise	4.72	100,000	472,000	141,763	Aug 26 08:20 PM
Benjamin Richard J	Chief Medical Officer	Aug 24	Sale	7.90	100,000	790,000	41,763	Aug 26 08:20 PM
ANDERSON TIMOTHY B	Director	Aug 24	Sale	7.90	16,008	126,463	210,101	Aug 26 08:18 PM
Moore Carol	SVP Reg. & Quality	Aug 12	Option Exercise	3.00	30,000	90,000	141,751	Aug 14 05:53 PM
Moore Carol	SVP Reg. & Quality	Aug 12	Sale	6.88	21,621	148,752	120,130	Aug 14 05:53 PM
Green Kevin Dennis	Chief Financial Officer	Aug 10	Option Exercise	2.08	80,000	166,400	200,981	Aug 11 09:15 PM
Green Kevin Dennis	Chief Financial Officer	Aug 10	Sale	6.96	68,585	477,678	132,396	Aug 11 09:15 PM
ANDERSON TIMOTHY B	Director	Aug 07	Option Exercise	4.34	43,800	190,092	242,482	Aug 11 09:16 PM
Menard Chrystal	Chief Legal Officer	Aug 07	Sale	7.07	23,621	166,930	48,585	Aug 11 09:18 PM
ANDERSON TIMOTHY B	Director	Aug 07	Sale	7.12	40,076	285,152	202,406	Aug 11 09:16 PM
Benjamin Richard J	Chief Medical Officer	Jul 07	Option Exercise	4.58	154,583	708,028	141,763	Jul 09 08:45 PM
Benjamin Richard J	Chief Medical Officer	Jul 07	Sale	7.20	154,583	1,113,044	41,763	Jul 09 08:45 PM
Moore Carol	SVP Reg. & Quality	Jun 25	Option Exercise	2.08	130,000	270,400	241,751	Jun 26 08:06 PM
Moore Carol	SVP Reg. & Quality	Jun 25	Sale	7.00	130,000	910,000	111,751	Jun 26 08:06 PM
Moore Carol	SVP Reg. & Quality	Jun 01	Option Exercise	3.00	30,025	90,057	141,751	Jun 03 09:40 PM
Moore Carol	SVP Reg. & Quality	Jun 01	Sale	6.50	30,025	195,163	111,751	Jun 03 09:40 PM
Menard Chrystal	Chief Legal Officer	May 12	Sale	5.67	20,351	115,288	72,206	May 14 06:22 PM
CORASH LAURENCE M	Chief Scientific Officer	Apr 22	Option Exercise	3.66	94,800	346,968	1,897,558	Apr 23 08:47 PM
Moore Carol	SVP Reg. & Quality	Mar 17	Sale	3.59	26,684	95,921	74,445	Mar 24 09:29 PM
Menard Chrystal	Chief Legal Officer	Mar 17	Sale	3.59	26,535	95,385	55,285	Mar 24 09:26 PM
Jayaraman Vivek K	Chief Commercial Officer	Mar 17	Sale	3.59	23,500	84,475	111,371	Mar 24 09:24 PM
Greenman William Mariner	President and CEO	Mar 17	Sale	3.59	108,011	388,267	699,590	Mar 24 09:19 PM
Green Kevin Dennis	Chief Financial Officer	Mar 17	Sale	3.59	26,625	95,709	83,612	Mar 24 09:15 PM
CORASH LAURENCE M	Chief Scientific Officer	Mar 17	Sale	3.59	17,500	62,907	1,802,758	Mar 24 09:12 PM
Benjamin Richard J	Chief Medical Officer	Mar 17	Sale	3.59	26,570	95,511	4,478	Mar 24 09:09 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience